SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as market participants react to recent news indicating efforts to significantly lower mortgage rates, which is broadly seen as a major catalyst for the housing market. The community is highly bullish, anticipating a potential short squeeze and strong upside as improved affordability could drive increased transaction volume for real estate platforms.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is a hot topic following significant announcements at CES 2026, where it unveiled new agentic voice and visual AI solutions for automotive and smart devices, including a collaboration with TomTom. The company's expanding presence in voice AI for robotics, automotive, and smart devices, alongside its considerable short interest, fuels a polarized debate between those anticipating a major breakout and others questioning its valuation and path to profitability.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending amid intense debate following a recent filing regarding convertible note conversions, which the company frames as a debt reduction. The community is sharply divided, with many fearing significant dilution from newly registered shares, while a strong bullish contingent anticipates a short squeeze, citing high cost to borrow and the stock's history of extreme volatility and parabolic price movements.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as its innovative Optical Interposer technology gains significant validation, notably following Marvell's acquisition of partner Celestial AI, underscoring its pivotal role in next-generation AI and data center optical interconnects. The community is buzzing about POET's patented, high-speed, and energy-efficient solutions, which are critical for scaling AI infrastructure beyond copper's limitations. Speculation is high for major upcoming orders and a substantial revenue ramp, positioning the company as a key player in the photonics sector.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors react sharply to disappointing preliminary Q4 results and conservative long-term revenue guidance for DefenCath, particularly concerning post-TDAPA reimbursement. While some view the drop as an overreaction to a known payment cliff, many in the community are voicing strong criticism of management's strategic decisions and recent acquisitions. Hope for recovery now hinges on upcoming pipeline catalysts like REZZAYO and potential support from the Kidney Care Access Protection Act.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health (OSCR) is a major talking point as investors await a crucial legislative outcome on the extension of Affordable Care Act subsidies, which heavily impacts its marketplace business. The community is sharply divided, with bulls anticipating a short squeeze and significant upside if an extension passes, while bears highlight ongoing legislative uncertainty and recent insider selling.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as community sentiment rallies around its latest advancements, including new processors built on advanced manufacturing processes showcased at a major tech event, fueling optimism for AI PCs and gaming. This positive momentum is significantly bolstered by strong endorsements from a former U.S. President, highlighting the government's substantial stake and its commitment to domestic chip manufacturing. Investors are actively discussing a potential long-term turnaround, with many anticipating Intel's renewed competitiveness in the semiconductor sector.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is gaining significant attention following news regarding proposed governmental action aimed at boosting the housing market and lowering mortgage rates. The community anticipates a substantial refinancing and home-buying boom, viewing RKT's integrated platform and scale as perfectly positioned to capitalize on these sector-wide tailwinds. Many express strong long-term optimism, seeing potential for significant upside as the market re-rates the company amidst a normalizing mortgage cycle and its enhanced ecosystem.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is trending due to renewed discussion surrounding potential shifts in its government conservatorship, ignited by recent statements from former President Trump regarding a directive for the entities to purchase mortgage bonds and efforts to lower mortgage rates. The community is actively debating whether this signals an imminent release from conservatorship, an IPO, or uplisting to a major exchange, with investors keenly focused on the implications for privatization and market performance, bolstered by prominent bullish voices like Bill Ackman and Michael Burry.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agenus (AGEN) Q3 2024 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Agenus (AGEN) Q1 2025 Earnings Call Transcript

Agenus (AGEN) Q4 2024 Earnings Call Transcript

Short Interest in Agenus Inc. (NASDAQ:AGEN) Rises By 56.5%

Agenus Inc. (NASDAQ:AGEN - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 2,774,043 shares...

Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating...

Agenus Inc. (NASDAQ:AGEN) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Agenus Inc. (NASDAQ:AGEN - Get Free Report) have been given an average rating of "Hold" by the five analysts that are currently covering the company, MarketBeat reports. One equities...

Agenus Inc. (NASDAQ:AGEN) Receives Average Rating of "Hold" from Analysts

Shares of Agenus Inc. (NASDAQ:AGEN - Get Free Report) have been given a consensus recommendation of "Hold" by the five brokerages that are presently covering the company, MarketBeat Ratings reports...

Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL

Agenus Inc. (Agenus) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its End-of-Year 2025 Stakeholder Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET. The session...

Agenus Appoints Dr. Jos Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including Frances AAC

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the appointment of Jos Iglesias, M.D. as Chief Medical Affairs Officer, effective November 10, 2025. Dr. Iglesias...

HC Wainwright Has Bullish Outlook for Agenus FY2025 Earnings

Agenus Inc. (NASDAQ:AGEN - Free Report) - Equities research analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Agenus in a note issued to investors on Tuesday...

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

SpaceX

Discord

OpenAI

Other - Comment Below

A few major private companies are being discussed as potential IPO candidates in 2026 — including SpaceX, Discord, Databricks, OpenAI, Anthropic, and Deel. IPO timelines can shift, but if one of these listings happens this year, which are you most excited to watch?

Which Potential 2026 IPO Are You Most Excited For?

AGEN
Agenus Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AGEN News

AGENAgenus Inc